Oct. 26: This week's recalls: Millions of pounds of ready-to-eat food, plus Ford Focus cars and BMWs
NDEA "occurs naturally in certain foods, drinking water, air pollution, and industrial processes," the FDA says.
Irbesartan is prescribed to treat high blood pressure and can be used to treat kidney disease in some patients, according to a U.S. National Library of Medicine publication.
As of Tuesday's release, ScieGen Pharmaceuticals was not aware of any adverse events related to the recall, the FDA reported.
On Oct. 26, the FDA announced that Aurobindo Pharma Limited recalled 22 batches of Irbesartan, which were sent to ScieGen Pharmaceuticals Inc., U.S. to be manufactured into the finished Irbesartan drug.
The Irbesartan recall follows a similar one in August for the heart drug valsartan.